Crossmark

Rate of unspecific bone uptake on PSMA PET is determined by the Scaffold – not the Radionuclide. Letter regarding: “The homunculus of unspecific bone uptakes associated with PSMA- targeted tracers: a systematic review-based definition” and “Cutting back on overdiagnosis – Occam’s razor and unspecific bone uptakes in PSMA PET“

Crossref DOI link: https://doi.org/10.1007/s00259-024-06897-2

Published Online: 2024-09-03

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rowe, Steven P.

Gorin, Michael A.
License Information

Text and Data Mining valid from 2024-09-03

Version of Record valid from 2024-09-03
More Information

Article History

Received: 5 August 2024

Accepted: 20 August 2024

First Online: 3 September 2024

Declarations

:

: SPR and MAG are consultants for Lantheus Medical Imaging, Blue Earth Diagnostics, and Telix Pharmaceuticals.

: SPR and MAG serve as consultants to Lantheus (the licensee of <sup>18</sup>F-DCFPyL). MAG is also a consultant for Telix (a marketer of <sup>68</sup>Ga-PSMA-11). No other relevant conflicts of interest were identified.

Document is current

Any future updates will be listed below